029-83533393
   info@TaiBSbio.com
 
组织芯片,组织微阵列
 
FOV1502卵巢腺癌组织芯片,附病理分级、TNM和临床分期,75例/150点
Zoom
点 数150例 数75
行 数10列 数15
点直径(mm)1.0厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.

产品名:FOV1502
 
卵巢腺癌组织微阵列芯片,含浆液性腺癌37例,粘液性腺癌18例,子宫内膜样腺癌5例,透明细胞癌3例,内胚窦癌3例,颗粒细胞瘤3例,神经内分泌癌1例,边缘组织5例,每例两点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Ova
-Ovary
 
Malignant (I)
 
Malignant (IA)
 
Malignant (IB)
 
Malignant (IC)
 
Malignant (II)
 
Malignant (IIB)
 
Malignant (III)
 
Malignant (IIIA)
 
Malignant (IIIC)
 
NAT (*)
TISSUE  ARRAYS FOV1502
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
A
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
B
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
C
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
D
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
E
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
F
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
G
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
H
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
I
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
J
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeTumor SizeisBackUp
A1129FOvarySerous adenocarcinoma1T1N0M0IMalignant*N
A2240FOvarySerous adenocarcinoma1T1aN0M0IAMalignant*N
A3341FOvarySerous adenocarcinoma1T1N0M0IMalignant6*4*2.5N
A4423FOvarySerous adenocarcinoma1T2bN0M0IIBMalignant2.8*2*1.5N
A5545FOvarySerous adenocarcinoma1T1aN0M0IAMalignant*N
A6635FOvarySerous papillary adenocarcinoma (interstitial)*T1cN0M0ICMalignant15*10*4N
A7775FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignant*N
A8849FOvarySerous adenocarcinoma2T1N0M0IMalignant8*4.5*4N
A9953FOvarySerous adenocarcinoma2T3N0M0IIIMalignant4*3*1.5N
A101039FOvarySerous adenocarcinoma2--3T3cN0M0IIICMalignant6*4*4N
A111149FOvarySerous adenocarcinoma3T1N0M0IMalignant6*5.5*5N
A121279FOvarySerous adenocarcinoma3T1aN0M0IAMalignant14*8*6N
A131356FOvarySerous adenocarcinoma3T1N0M0IMalignant6*5*3N
A141457FOvarySerous adenocarcinoma3T1N0M0IMalignant9*5*4N
A151558FOvarySerous adenocarcinoma3T1N0M0IMalignant9*5.5*2N
B11629FOvarySerous adenocarcinoma1T1N0M0IMalignant*N
B21740FOvarySerous adenocarcinoma1T1aN0M0IAMalignant*N
B31841FOvarySerous adenocarcinoma1T1N0M0IMalignant6*4*2.5N
B41923FOvarySerous adenocarcinoma1T2bN0M0IIBMalignant2.8*2*1.5N
B52045FOvarySerous adenocarcinoma1T1aN0M0IAMalignant*N
B62135FOvarySerous papillary adenocarcinoma2T1cN0M0ICMalignant15*10*4N
B72275FOvarySerous papillary adenocarcinoma2T1aN0M0IAMalignant*N
B82349FOvarySerous adenocarcinoma2T1N0M0IMalignant8*4.5*4N
B92453FOvarySerous adenocarcinoma2T3N0M0IIIMalignant4*3*1.5N
B102539FOvarySerous adenocarcinoma2--3T3cN0M0IIICMalignant6*4*4N
B112649FOvarySerous adenocarcinoma3T1N0M0IMalignant6*5.5*5N
B122779FOvarySerous adenocarcinoma3T1aN0M0IAMalignant14*8*6N
B132856FOvarySerous adenocarcinoma3T1N0M0IMalignant6*5*3N
B142957FOvarySerous adenocarcinoma3T1N0M0IMalignant9*5*4N
B153058FOvarySerous adenocarcinoma3T1N0M0IMalignant9*5.5*2N
C13151FOvarySerous adenocarcinoma3T1bN0M0IBMalignant8*6*2N
C23275FOvarySerous adenocarcinoma with sparse necrosis3T1N0M0IMalignant5*4*3N
C33351FOvarySerous adenocarcinoma with sparse necrosis3T1aN0M0IAMalignant7*6*4N
C43443FOvarySerous adenocarcinoma3T3N0M0IIIMalignant*N
C53553FOvarySerous adenocarcinoma2T3N1M0IIICMalignant3*2*1N
C63655FOvarySerous adenocarcinoma2--3T1aN0M0IAMalignant4.5*3.0*3.0N
C73741FOvarySerous adenocarcinoma with sparse necrosis3T3N0M0IIIMalignant*N
C83855FOvarySerous adenocarcinoma3T1cN0M0ICMalignant9.0N
C93967FOvarySerous adenocarcinoma3T1aN0M0IAMalignant9*6*5.5N
C104048FOvarySerous adenocarcinoma3T3aN0M0IIIAMalignant7*4*2.5N
C114167FOvarySerous adenocarcinoma3T1N0M0IMalignant13*12*6N
C124243FOvarySerous adenocarcinoma3T3cN0M0IIICMalignant8*7*4N
C134337FOvarySerous adenocarcinoma2T1aN0M0IAMalignant6.5*4.5*3.0N
C144449FOvarySerous adenocarcinoma3T3N1M0IIICMalignant9.0N
C154558FOvarySerous adenocarcinoma3T3cN0M0IIICMalignant*N
D14651FOvarySerous adenocarcinoma3T1bN0M0IBMalignant8*6*2N
D24775FOvarySerous adenocarcinoma (sparse)3T1N0M0IMalignant5*4*3N
D34851FOvarySerous adenocarcinoma with sparse necrosis3T1aN0M0IAMalignant7*6*4N
D44943FOvarySerous adenocarcinoma2--3T3N0M0IIIMalignant*N
D55053FOvarySerous adenocarcinoma with nerosis (sparse)2T3N1M0IIICMalignant3*2*1N
D65155FOvarySerous adenocarcinoma2T1aN0M0IAMalignant4.5*3.0*3.0N
D75241FOvarySerous adenocarcinoma with sparse necrosis3T3N0M0IIIMalignant*N
D85355FOvarySerous adenocarcinoma3T1cN0M0ICMalignant9.0N
D95467FOvarySerous adenocarcinoma3T1aN0M0IAMalignant9*6*5.5N
D105548FOvarySerous adenocarcinoma with sparse necrosis3T3aN0M0IIIAMalignant7*4*2.5N
D115667FOvarySerous adenocarcinoma3T1N0M0IMalignant13*12*6N
D125743FOvarySerous adenocarcinoma (sparse)3T3cN0M0IIICMalignant8*7*4N
D135837FOvarySerous adenocarcinoma3T1aN0M0IAMalignant6.5*4.5*3.0N
D145949FOvarySerous adenocarcinoma with sparse necrosis3T3N1M0IIICMalignant9.0N
D156058FOvarySerous adenocarcinoma3T3cN0M0IIICMalignant*N
E16143FOvarySerous adenocarcinoma3T1aN0M0IAMalignant*N
E26256FOvarySerous adenocarcinoma3T1aN0M0IAMalignant*N
E36352FOvarySerous adenocarcinoma2T3N0M0IIIMalignant*N
E46450FOvarySerous adenocarcinoma3T1aN0M0IAMalignant*N
E56540FOvarySerous adenocarcinoma (interstitial)*T1aN0M0IAMalignant*N
E66647FOvarySerous adenocarcinoma3T1aN1M0IIICMalignant7.0N
E76746FOvarySerous adenocarcinoma3T2bN1M0IIICMalignant6.0N
E86869FOvaryMucinous adenocarcinoma1T1bN0M0IBMalignant*N
E96934FOvaryMucinous adenocarcinoma1T1bN0M0IBMalignant*N
E107054FOvaryMucinous adenocarcinoma1T1bN0M0IBMalignant*N
E117149FOvaryMucinous adenocarcinoma1T1N0M0IMalignant8.5*6*2N
E127235FOvaryMucinous adenocarcinoma2T1bN0M0IBMalignant*N
E137357FOvaryMucinous adenocarcinoma2T1bN0M0IBMalignant10*10N
E147448FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignant*N
E157535FOvaryMucinous adenocarcinoma (necrosis)*T3aN1M0IIICMalignant24*16*9N
F17643FOvarySerous adenocarcinoma3T1aN0M0IAMalignant*N
F27756FOvarySerous adenocarcinoma3T1aN0M0IAMalignant*N
F37852FOvarySerous adenocarcinoma2T3N0M0IIIMalignant*N
F47950FOvarySerous adenocarcinoma3T1aN0M0IAMalignant*N
F58040FOvarySerous adenocarcinoma3T1aN0M0IAMalignant*N
F68147FOvarySerous adenocarcinoma with sparse necrosis3T1aN1M0IIICMalignant7.0N
F78246FOvarySerous adenocarcinoma3T2bN1M0IIICMalignant6.0N
F88369FOvaryMucinous adenocarcinoma1T1bN0M0IBMalignant*N
F98434FOvaryMucinous adenocarcinoma1T1bN0M0IBMalignant*N
F108554FOvaryMucinous adenocarcinoma (sparse)1T1bN0M0IBMalignant*N
F118649FOvaryMucinous adenocarcinoma1T1N0M0IMalignant8.5*6*2N
F128735FOvaryMucinous adenocarcinoma2T1bN0M0IBMalignant*N
F138857FOvaryMucinous adenocarcinoma with sparse necrosis2T1bN0M0IBMalignant10*10N
F148948FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignant*N
F159035FOvaryMucinous adenocarcinoma with necrosis2T3aN1M0IIICMalignant24*16*9N
G19141FOvaryMucinous adenocarcinoma with necrosis (sparse)2T1aN0M0IAMalignant*N
G29240FOvaryMucinous adenocarcinoma2T1cN0M0ICMalignant*N
G39367FOvaryMucinous adenocarcinoma2T1N0M0IMalignant*N
G49447FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignant7*5*4N
G59549FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignant5*4*3.5N
G69652FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignant*N
G79754FOvaryMucinous adenocarcinoma3T1N0M0IMalignant11*6*5N
G89861FOvaryMucinous adenocarcinoma3T1cN0M0ICMalignant*N
G99950FOvaryMucinous adenocarcinoma3T2N0M0IIMalignant7*4*4N
G1010045FOvaryMucinous adenocarcinoma3T1aN0M0IAMalignant*N
G1110155FOvaryEndometrioid adenocarcinoma1--2T1aN0M0IAMalignant11*9*7N
G1210244FOvaryEndometrioid adenocarcinoma2T1bN0M0IBMalignant*N
G1310360FOvaryEndometrioid adenocarcinoma2T3N0M0IIIMalignant*N
G1410449FOvaryEndometrioid adenocarcinoma2T1aN0M0IAMalignant12*11*5N
G1510554FOvaryEndometrioid adenocarcinoma2T1bN0M0IBMalignant4.5*2.5*2N
H110641FOvaryMucinous adenocarcinoma (necrosis)*T1aN0M0IAMalignant*N
H210740FOvaryMucinous adenocarcinoma2T1cN0M0ICMalignant*N
H310867FOvaryMucinous adenocarcinoma2T1N0M0IMalignant*N
H410947FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignant7*5*4N
H511049FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignant5*4*3.5N
H611152FOvaryMucinous adenocarcinoma2T1aN0M0IAMalignant*N
H711254FOvaryMucinous adenocarcinoma3T1N0M0IMalignant11*6*5N
H811361FOvaryMucinous adenocarcinoma3T1cN0M0ICMalignant*N
H911450FOvaryMucinous adenocarcinoma2--3T2N0M0IIMalignant7*4*4N
H1011545FOvaryMucinous adenocarcinoma3T1aN0M0IAMalignant*N
H1111655FOvaryEndometrioid adenocarcinoma1--2T1aN0M0IAMalignant11*9*7N
H1211744FOvaryEndometrioid adenocarcinoma2T1bN0M0IBMalignant*N
H1311860FOvaryEndometrioid adenocarcinoma2T3N0M0IIIMalignant*N
H1411949FOvaryEndometrioid adenocarcinoma2T1aN0M0IAMalignant12*11*5N
H1512054FOvaryEndometrioid adenocarcinoma2T1bN0M0IBMalignant4.5*2.5*2N
I112161FOvaryClear cell carcinoma2T1aN0M0IAMalignant12*6*6N
I212242FOvaryClear cell carcinoma2T1aN0M0IAMalignant9.5*5*1N
I312343FOvaryClear cell carcinoma2T1aN0M0IAMalignant7*4*3N
I412412FOvaryEndodermal sinus tumor*T1bN0M0IBMalignant13*8*8N
I512514FOvaryEndodermal sinus tumor*T1cN0M0ICMalignant15*13*10N
I612619FOvaryEndodermal sinus tumor*T1aN0M0IAMalignant11*10*9N
I712784FOvaryGranular cell tumor*T1aN0M0IAMalignant10*6*0.8N
I812810FOvaryJuvenile granulosa cell tumor*T1aN0M0IAMalignant12*9*6N
I912949FOvaryGranular cell tumor*T1N0M0IMalignant8*7*6N
I1013045FOvaryNeuroendocrine carcinoma with necrosis*T1aN0M0IAMalignant5.0*4.5*3.0N
I1113148FOvaryAdjacent normal ovary tissue***NAT*N
I1213229FOvaryAdjacent normal ovary tissue***NAT*N
I1313351FOvaryAdjacent normal ovary tissue***NAT*N
I1413452FOvaryAdjacent normal ovary tissue***NAT*N
I1513541FOvaryAdjacent normal ovary tissue***NAT*N
J113661FOvaryClear cell carcinoma2T1aN0M0IAMalignant12*6*6N
J213742FOvaryClear cell carcinoma2T1aN0M0IAMalignant9.5*5*1N
J313843FOvaryClear cell carcinoma2T1aN0M0IAMalignant7*4*3N
J413912FOvaryEndodermal sinus cancer*T1bN0M0IBMalignant13*8*8N
J514014FOvaryEndodermal sinus cancer*T1cN0M0ICMalignant15*13*10N
J614119FOvaryEndodermal sinus cancer*T1aN0M0IAMalignant11*10*9N
J714284FOvaryGranular cell tumor*T1aN0M0IAMalignant10*6*0.8N
J814310FOvaryJuvenile granulosa cell tumor*T1aN0M0IAMalignant12*9*6N
J914449FOvaryGranular cell tumor*T1N0M0IMalignant8*7*6N
J1014545FOvaryNeuroendocrine carcinoma*T1aN0M0IAMalignant5.0*4.5*3.0N
J1114648FOvaryAdjacent normal ovary tissue***NAT*N
J1214729FOvaryAdjacent normal ovary tissue***NAT*N
J1314851FOvaryAdjacent normal ovary tissue***NAT*N
J1414952FOvaryAdjacent normal ovary tissue***NAT*N
J1515041FOvaryAdjacent normal ovary tissue***NAT*N
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址:陕西西安市灞桥区长乐东路2999号
电话:029-83533393, 17792711553,
电子邮箱:taibsbio@163.com
QQ:3144647811
微信号:13002913390
邮政编码:710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售,加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队,并且具有庞大的组织标本库。样本库中组织微阵列种类多,病理类型齐全,同时根据客户需求情况进行制作加工新的组织微阵列,尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度,致力于为广大客户提供质量好的产品和优质的服务。

更多详情